Atlas Trials

An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy

Clinical trial NCT04794491 · COMPLETED

Trial details

NCT number
NCT04794491
Sponsor
Jazz Pharmaceuticals
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Narcolepsy
Start date
2021-03-22
Primary completion
2022-11-15
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.